vs
Protagonist Therapeutics, Inc（PTGX）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是Protagonist Therapeutics, Inc的1.2倍（$212.2M vs $170.6M），Protagonist Therapeutics, Inc净利率更高（77.2% vs 18.8%，领先58.4%），Protagonist Therapeutics, Inc同比增速更快（184.4% vs 8.6%）
Protagonist Therapeutics是一家临床阶段生物制药公司，专注于研发创新肽类靶向疗法，以满足胃肠道疾病、炎症性疾病及罕见病领域未被满足的医疗需求，核心候选产品覆盖炎症性肠病等慢性免疫相关适应症。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
PTGX vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.2倍
$170.6M
营收增速更快
PTGX
高出175.8%
8.6%
净利率更高
PTGX
高出58.4%
18.8%
损益表 — Q4 FY2024 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $170.6M | $212.2M |
| 净利润 | $131.7M | $39.9M |
| 毛利率 | — | 71.9% |
| 营业利润率 | 74.3% | 18.6% |
| 净利率 | 77.2% | 18.8% |
| 营收同比 | 184.4% | 8.6% |
| 净利润同比 | 381.7% | 255.7% |
| 每股收益（稀释后） | $2.01 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PTGXRAMP
| Q4 25 | — | $212.2M | ||
| Q3 25 | — | $199.8M | ||
| Q2 25 | — | $194.8M | ||
| Q1 25 | — | $188.7M | ||
| Q4 24 | $170.6M | $195.4M | ||
| Q3 24 | — | $185.5M | ||
| Q2 24 | — | $176.0M | ||
| Q1 24 | $255.0M | $171.9M |
净利润PTGXRAMP
| Q4 25 | — | $39.9M | ||
| Q3 25 | — | $27.4M | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | — | $-6.3M | ||
| Q4 24 | $131.7M | $11.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $-7.5M | ||
| Q1 24 | $207.3M | $-5.4M |
毛利率PTGXRAMP
| Q4 25 | — | 71.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | — | 70.1% | ||
| Q1 25 | — | 69.3% | ||
| Q4 24 | — | 71.9% | ||
| Q3 24 | — | 72.4% | ||
| Q2 24 | — | 70.6% | ||
| Q1 24 | — | 72.2% |
营业利润率PTGXRAMP
| Q4 25 | — | 18.6% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | -6.1% | ||
| Q4 24 | 74.3% | 7.5% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | -3.0% | ||
| Q1 24 | 80.9% | -8.3% |
净利率PTGXRAMP
| Q4 25 | — | 18.8% | ||
| Q3 25 | — | 13.7% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | — | -3.3% | ||
| Q4 24 | 77.2% | 5.7% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | -4.3% | ||
| Q1 24 | 81.3% | -3.1% |
每股收益（稀释后）PTGXRAMP
| Q4 25 | — | $0.62 | ||
| Q3 25 | — | $0.42 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $-0.10 | ||
| Q4 24 | $2.01 | $0.17 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.11 | ||
| Q1 24 | $3.26 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $418.9M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $675.3M | $962.3M |
| 总资产 | $744.7M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PTGXRAMP
| Q4 25 | — | $403.4M | ||
| Q3 25 | — | $376.9M | ||
| Q2 25 | — | $371.1M | ||
| Q1 25 | — | $420.8M | ||
| Q4 24 | $418.9M | $384.3M | ||
| Q3 24 | — | $348.4M | ||
| Q2 24 | — | $342.7M | ||
| Q1 24 | $322.6M | $368.9M |
股东权益PTGXRAMP
| Q4 25 | — | $962.3M | ||
| Q3 25 | — | $943.8M | ||
| Q2 25 | — | $947.8M | ||
| Q1 25 | — | $948.9M | ||
| Q4 24 | $675.3M | $957.7M | ||
| Q3 24 | — | $932.1M | ||
| Q2 24 | — | $951.9M | ||
| Q1 24 | $560.4M | $949.1M |
总资产PTGXRAMP
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $744.7M | $1.3B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | $629.3M | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $184.2M | — |
| 自由现金流经营现金流 - 资本支出 | $182.8M | — |
| 自由现金流率自由现金流/营收 | 107.1% | — |
| 资本支出强度资本支出/营收 | 0.8% | 0.1% |
| 现金转化率经营现金流/净利润 | 1.40× | — |
| 过去12个月自由现金流最近4个季度 | $101.7M | — |
8季度趋势，按日历期对齐
经营现金流PTGXRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | $57.4M | ||
| Q2 25 | — | $-15.8M | ||
| Q1 25 | — | — | ||
| Q4 24 | $184.2M | $45.1M | ||
| Q3 24 | — | $55.6M | ||
| Q2 24 | — | $-9.3M | ||
| Q1 24 | $-27.4M | — |
自由现金流PTGXRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | $56.8M | ||
| Q2 25 | — | $-16.2M | ||
| Q1 25 | — | — | ||
| Q4 24 | $182.8M | $44.8M | ||
| Q3 24 | — | $55.4M | ||
| Q2 24 | — | $-9.6M | ||
| Q1 24 | $-27.7M | — |
自由现金流率PTGXRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | 28.4% | ||
| Q2 25 | — | -8.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | 107.1% | 22.9% | ||
| Q3 24 | — | 29.8% | ||
| Q2 24 | — | -5.4% | ||
| Q1 24 | -10.9% | — |
资本支出强度PTGXRAMP
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | 0.8% | 0.1% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | 0.1% | 1.0% |
现金转化率PTGXRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | 2.09× | ||
| Q2 25 | — | -2.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.40× | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
